Upstream Bio jumps in market debut

Upstream Bio

11/10/2024 17:57

** U.S. healthcare startup Upstream Bio's  UPB.O  shares
rise ~26.47% above their initial public offering price in co's
market debut
    ** UPB last up ~23.5% at $21; stock opened for trading at
$21.50 vs IPO price of $17
    ** UPB, in a sign of strong investor demand, priced its
upsized IPO at higher end of its marketed range of $15 to $17
    ** With the shares' rise at debut, UPB now valued aT $1.05
bln
    ** Co raised $255 mln by selling 15 mln shares priced at $17
apiece
    ** J.P. Morgan, TD Cowen, Piper Sandler and William Blair
were the underwriters for the IPO


 (Reporting by Prakhar Srivastava in Bengaluru)
 ((Prakhar.srivastava2@thomsonreuters.com))